Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1994-3-4
pubmed:abstractText
Heparin-binding (HB) epidermal growth factor (EGF)-like growth factor (HB-EGF), a member of the EGF protein family, is a potent mitogen for fibroblasts, smooth muscle cells, and keratinocytes that was initially identified as a secreted product of macrophage-like cells. HB-EGF and EGF appear to act on target cells utilizing the same receptor, but HB-EGF is distinguishable from EGF by its strong affinity for heparin. To facilitate studies of structure-function relationships in HB-EGF, a bacterial recombinant expression system was established that produced biologically active HB-EGF with the expected disulfide bonding pattern. Mutagenesis and protease digestion studies of the recombinant HB-EGF, coupled with heparin-binding analyses of synthetic peptides, indicated that the sequences within HB-EGF mediating its interaction with heparin are located primarily in a stretch of 21 amino acids characterized by a high content of lysine and arginine residues. Most of this heparin-binding domain lies in an amino-terminal region of HB-EGF that has no counterpart in EGF, but a portion of the 21-residue sequence extends into the EGF-like region of HB-EGF. In addition, the mutagenesis and synthetic peptide studies indicated that sequences in HB-EGF lying outside of the 21-residue stretch can also influence the interaction with heparin. Finally, a synthetic peptide derived from the 21-residue stretch was found to compete with HB-EGF for binding to Chinese hamster ovary cells, suggesting that the heparin-binding sequences in HB-EGF may also mediate the interaction of this factor with cell surface heparan sulfate proteoglycan.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0021-9258
pubmed:author
pubmed:issnType
Print
pubmed:day
28
pubmed:volume
269
pubmed:owner
NLM
pubmed:authorsComplete
N
pubmed:pagination
2541-9
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:8300582-Amino Acid Sequence, pubmed-meshheading:8300582-Animals, pubmed-meshheading:8300582-Binding Sites, pubmed-meshheading:8300582-CHO Cells, pubmed-meshheading:8300582-Cell Division, pubmed-meshheading:8300582-Cell Line, pubmed-meshheading:8300582-Chromatography, High Pressure Liquid, pubmed-meshheading:8300582-Cloning, Molecular, pubmed-meshheading:8300582-Cricetinae, pubmed-meshheading:8300582-Epidermal Growth Factor, pubmed-meshheading:8300582-Escherichia coli, pubmed-meshheading:8300582-Heparin, pubmed-meshheading:8300582-Humans, pubmed-meshheading:8300582-Intercellular Signaling Peptides and Proteins, pubmed-meshheading:8300582-Mice, pubmed-meshheading:8300582-Mitogens, pubmed-meshheading:8300582-Molecular Sequence Data, pubmed-meshheading:8300582-Recombinant Fusion Proteins, pubmed-meshheading:8300582-Recombinant Proteins, pubmed-meshheading:8300582-Tumor Cells, Cultured
pubmed:year
1994
pubmed:articleTitle
Characterization of sequences within heparin-binding EGF-like growth factor that mediate interaction with heparin.
pubmed:affiliation
Scios Nova Inc., Mountain View, California 94043.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.